Carregant...
Preoperative use of anti-tumor necrosis factor therapy in Crohn's disease: promises and pitfalls
Recent advances in medical and surgical therapy were achieved during the last two decades in the management of Crohn's disease (CD). Anti-tumor necrosis factor (anti-TNF) agents are widely used worldwide. However, a significant proportion of patients still need surgical resections. The impact o...
Guardat en:
| Publicat a: | Intest Res |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Korean Association for the Study of Intestinal Diseases
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5430006/ https://ncbi.nlm.nih.gov/pubmed/28522944 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5217/ir.2017.15.2.160 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|